Clinical experience with dual-acting drugs in hypertension

K H Rahn1

  • 1Department of Medicine D, Universität Münster.

The Clinical Investigator
|January 1, 1992
PubMed

Insights

Dual-action antihypertensive agents like labetalol and carvedilol are effective for chronic hypertension and emergencies. Celiprolol

Area of Science:

  • Pharmacology and Therapeutics
  • Cardiovascular Medicine

Background:

  • Several antihypertensive medications with dual mechanisms of action are available.
  • Labetalol is the most extensively studied dual-action agent, used for chronic hypertension and hypertensive emergencies.
  • Carvedilol is effective for various forms of hypertension.

Purpose of the Study:

  • To review the role and efficacy of dual-action antihypertensive agents.
  • To highlight the established uses of labetalol and carvedilol.
  • To discuss the receptor binding profile of celiprolol and its potential contribution to its antihypertensive effect.

Main Methods:

  • Review of existing literature on dual-action antihypertensive agents.
  • Analysis of clinical studies on labetalol, carvedilol, and celiprolol.
  • Examination of pharmacological properties, including receptor binding.

Main Results:

  • Labetalol is a well-established treatment for chronic hypertension and hypertensive emergencies.
  • Carvedilol demonstrates efficacy across different hypertensive conditions.
  • Celiprolol exhibits binding to beta 1-, beta 2-, and alpha 2-receptors, though the clinical significance of alpha 2-receptor binding is not yet fully understood.

Conclusions:

  • Dual-action antihypertensives, particularly labetalol and carvedilol, offer valuable therapeutic options.
  • Further research is needed to elucidate the precise role of celiprolol's alpha 2-receptor binding in its antihypertensive action.

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...